Acutus Medical Inc
AFIB
AFIB was delisted on the 8th of May, 2024.
69 hedge funds and large institutions have $569M invested in Acutus Medical Inc in 2020 Q3 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$166M |
| 2 |
DM
Deerfield Management
New York
|
+$132M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$31.4M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$22.8M |
| 5 |
BlackRock
New York
|
+$20.6M |
Top Sellers
AFIB Hedge Fund Activity: Q3 2020 in Review
69 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q3 2020, worth a combined $569M.
Buyers outnumbered sellers: 69 funds opened new AFIB positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $166M.
- 69 institutional investors held Acutus Medical Inc (AFIB) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $569M of Acutus Medical Inc stock for Q3 2020.
- 69 funds opened new Acutus Medical Inc positions in Q3 2020 and 0 closed out, a net change of +69 holders.
- The largest Acutus Medical Inc buyer in Q3 2020 was OrbiMed, an estimated $166M added.
Based on aggregated 13F filings for Q3 2020.